September 3 - 6, 2012, University of Lausanne, Zwitserland
This course aims to provide an overview of all parts of the vaccine development pipeline. The course is ideally suited to persons working in vaccine development who wish to expand and broaden their knowledge of the field. A maximum of 15 participants will be selected, via a competitive process, to attend this four-day full-time training course. The course is run by the TRANSVAC project which is funded by the European Commission’s Seventh Framework Programme.
The course will be conducted at the Vaccine Formulation Laboratory training center, University of Lausanne, Epalinges, Switzerland.
Business Development Aspects, Antigen Systems, Fermentation Media,
Downstream Processing, Formulation, Animal Models, Stability Studies,
Toxicology, GLP, and Clinical Dossiers.
Registration fees and costs
Participants’ course registration fees and hotel accommodation costs are fully covered by the TRANSVAC project. All other costs are the responsibility of the participant or their employer.
All persons working within any aspect of vaccine development, as well as those who can demonstrate that the course would be of benefit to them and their organization, are eligible to apply. In addition, participants must either be working in a European Union or Associated Member State, or be working in a vaccine development project funded by the European Commission or EDCTP (irrelevant of global location). Candidates should also possess a BSc or MSc, or have demonstrable vaccine-related research experience.
The closing date for receipt of applications is 30 June 2012 at 5pm GMT